M&G Global Emerging Markets Fund Sterling I Inc
Category Global Emerging Markets Equity
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
307.57p
2.53p (+0.83%)
Fund Code
MGGKI
B3FFXY5
GB00B3FFXY53
Prices updated as at 28 May 2025
Prices in GBX
Investment objective
The Fund aims to provide a higher total return (the combination of capital growth and income), net of the Ongoing Charge Figure, than that of the MSCI Emerging Markets Index over any five-year period. At least 80% of the Fund is invested directly in equity securities and equity-related securities of companies across any sector and market capitalisation that are incorporated, domiciled or do most of their business in Emerging Market countries.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Annual performance (%)
Year | This fund | Global Emerging Markets Equity |
---|---|---|
31 Mar 14 - 31 Mar 15 | 6.09 | 11.33 |
31 Mar 15 - 31 Mar 16 | -8.44 | -8.25 |
31 Mar 16 - 31 Mar 17 | 39.65 | 33.47 |
31 Mar 17 - 31 Mar 18 | 3.01 | 8.88 |
31 Mar 18 - 31 Mar 19 | 2.57 | -1.83 |
31 Mar 19 - 31 Mar 20 | -23.06 | -14.75 |
31 Mar 20 - 31 Mar 21 | 48.23 | 44.20 |
31 Mar 21 - 31 Mar 22 | 1.93 | -9.25 |
31 Mar 22 - 31 Mar 23 | 5.00 | -4.79 |
31 Mar 23 - 31 Mar 24 | 10.30 | 5.69 |
31 Mar 24 - 31 Mar 25 | 4.40 | 3.63 |
Trailing returns (%)
Year | This fund | Global Emerging Markets Equity |
---|---|---|
1 Day | 0.83 | 0.45 |
1 Month | 5.60 | 5.44 |
3 Months | 0.30 | 0.14 |
6 Months | 2.41 | 1.97 |
1 Year | 2.92 | 2.82 |
3 Years annualised | 7.46 | 4.11 |
5 Years annualised | 10.95 | 5.13 |
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.